Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
CSL recognizes patients around the globe who live with bleeding disorders such as hemophilia. Continued innovation and improv…
Lab automation is helping CSL R&D scientific staff to generate and process data more quickly, enhance reproducibility and be …
Get three fast facts about antibodies, which play an essential role in the immune system and help fight infections.
On Rare Disease Day, CSL brought together a team of volunteers who pedaled during daylight hours to generate energy needed fo…
Clotting factors are proteins in blood plasma that prevent excessive bleeding. They’re essential to the cascade of events cal…
CSL has committed to set near-term companywide greenhouse gas (GHG) emissions reductions targets, in line with climate scienc…
CSL Chief Sustainability Officer Jeffrey Ball looks ahead to Earth Day on April 22 and shares highlights, including CSL’s ren…
We recognize physicians and the demands of continuous learning – especially when treating patients who have rare conditions. …
Diana Lanchoney in CSL’s Clinical Development Operations is a Luminary and Payal Patel, Site Head of Engineering at CSL Seqir…
Americas
Asia Pacific
Middle East
Europe
